Crinetics Pharmaceuticals, Inc.
$84.84
-0.01 (-0.01%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- +1.4%
- 3 Months
- +138.6%
- YTD
- +82.3%
- 1 Year
- +179.1%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 112.6%
- Largest decline max drawdown, since Aug 2025
- -42.2%
- Risk-adjusted return Sharpe ratio, 1-year
- 1.30
Own CRNX?
See how CRNX contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.